Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases

Medical Mycology

Volumn 47, Issue 4, 2009, Pages 359-370

  Rodriguez Tudela, Juan Luis ^a   Berenguer, Juan ^b   Guarro, Josep ^c   Kantarcioglu, A Serda ^d   Horre, Regine ^e   Sybren De Hoog, G ^f,g   Cuenca Estrella, Manuel ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^c FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^d ISTANBUL UNIVERSITY   (Turkey)

^e UNIVERSITY OF BONN   (Germany)

^f CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

^g UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Risk factors; Scedosporium prolificans; Treatment

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; COLONY STIMULATING FACTOR; FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE; TERBINAFINE; VORICONAZOLE; ANTIFUNGAL AGENT;

ARTICLE; BLOOD CULTURE; BONE INFECTION; CENTRAL NERVOUS SYSTEM INFECTION; COMORBIDITY; CYSTIC FIBROSIS; ENUCLEATION; EXTERNAL OTITIS; EYE INFECTION; FEVER; HUMAN; INFECTION RISK; INFECTIOUS ARTHRITIS; LUNG MYCOSIS; MALIGNANT NEOPLASTIC DISEASE; MORTALITY; MYCOSIS; ORGAN TRANSPLANTATION; OSTEOMYELITIS; SCEDOSPORIUM; SCEDOSPORIUM PROLIFICANS; SKIN INFECTION; SURVIVAL RATE; SYMPTOM; WOUND INFECTION; ADOLESCENT; ADULT; AGED; CHILD; DRUG EFFECT; FEMALE; INFANT; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; REVIEW; RISK FACTOR; TREATMENT OUTCOME;

SCEDOSPORIUM PROLIFICANS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; MYCOSES; RISK FACTORS; SCEDOSPORIUM; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67449087561     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802524506     Document Type: Article

References (76)

1. Hennebert GL, Dessai BG. Lomentospora prolificans, a new hyphomycete from greenhouse soil. Mycotaxon 1974; 1: 50.
2. Malloch D, Salkin IF. A new species of Scedosporium associated with osteomyelitis in humans. Mycotaxon 1984; 21: 247-255.
3. Gueho E, de Hoog GS. Taxonomy of the medical species of Pseudallescheria and Scedosporium. J Mycol Med 1991; 118: 3-9.
4. Berenguer J, Rodriguez-Tudela JL, Richard C, et al. Deep infections caused by Scedosporium prolificans. A report on 16 cases in Spain and a review of the literature. Scedosporium prolificans Spanish Study Group. Medicine (Baltimore) 1997; 76: 256-265.
5. Guarro J, Gaztelurrutia L, Marin J, Barcena J. Scedosporium inflatum, a new pathogenic fungus. Report of 2 cases with a fatal outcome]. Enferm Infecc Microbiol Clin 1991; 9: 557-560.
6. Marin J, Sanz MA, Sanz GF, et al. Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis 1991; 10: 759-761.
7. Alvarez M, Lopez PB, Rayon C, et al. Nosocomial outbreak caused by Scedosporium prolificans (inflatum): Four fatal cases in leukemic patients. J Clin Microbiol 1995; 33: 3290-3295.
8. Aranguena LG, Zurbano F, Cifrian JM, et al. [Colonization/ infection of pulmonary graft by Scedosporium inflatum. Enferm Infecc Microbiol Clin 1997; 15: 437-438.
9. Arthur S, Steed LL, Apple DJ, et al. Scedosporium prolificans keratouveitis in association with a contact lens retained intraocularly over a long term. J Clin Microbiol 2001; 39: 4579-4582.
10. Bouza E, Munoz P, Vega L, et al. Clinical resolution of Scedosporium prolificans fungemia associated with reversal of neutropenia following administration of granulocyte colony-stimulating factor. Clin Infect Dis 1996; 23: 192-193.
11. Carreter de Granda ME, Richard C, Conde E, et al. Endocarditis caused by Scedosporium prolificans after autologous peripheral blood stem cell transplantation. Eur J Clin Microbiol Infect Dis 2001; 20: 215-217.
12. Chikhani L, Dupont B, Guilbert F, et al. Uncommon fungal maxillary sinusitis of dental origin due to Scedosporium prolificans. Rev Stomatol Chir Maxillofac 1995; 96: 66-69.
13. de Batlle J, Motje M, Balanza R, Guardia R, Ortiz R. Disseminated infection caused by Scedosporium prolificans in a patient with acute multilineal leukemia. J Clin Microbiol 2000; 38: 1694-1695.
14. del Palacio A, Cuetara MS, Lumbreras C, Gonzalez A, Gomez C. [Transitory colonization by Scedosporium prolificans (inflatum) in a liver transplant recipient]. Enferm Infecc Microbiol Clin 1994; 12 523-524.
15. del Palacio A, Garau M, Amor E, et al. Case reports. Transient colonization with Scedosporium prolificans. Report of four cases in Madrid. Mycoses 2001; 44: 321-325.
16. Diaz MC, Juliet C, Mdl TA, Rodriguez-Tudela JL. [Surgical site abscess by Scedosporium prolificans: First report in Chile and review]. Rev Chil Infect 2004; 21: 65-69.
17. Farag SS, Firkin FC, Andrew JH, Lee CS, Ellis DH. Fatal disseminated Scedosporium inflatum infection in a neutropenic immunocompromised patient. J Infect 1992; 25: 201-204.
18. Feltkamp MC, Kersten MJ, van der LJ, et al. Fatal Scedosporium prolificans infection in a leukemic patient. Eur J Clin Microbiol Infect Dis 1997; 16: 460-464.
19. Fernandez-Mosteirin N, Salvador-Osuna C, Mayayo P, Garcia-Zueco JC. Scedosporium prolificans: Disseminated infection in immunocompromised patient]. Med Clin (Barc) 2003; 120: 317-318.
20. Garcia E, Rodriguez V, Gartner S, Gene J. [Isolation of Scedosporium prolificans in patients with cystic fibrosis]. Enferm Infecc Microbiol Clin 1998; 16: 488-489.
21. Gillum PS, Gurswami A, Taira JW. Localized cutaneous infection by Scedosporium prolificans (inflatum). Int J Dermatol 1997; 36 297-299.
22. Gonzalez PA, del Palacio A, Perez Pomata MT, et al. [Fungemia caused by Scedosporium prolificans (inflatum) in a patient with AIDS]. Enferm Infecc Microbiol Clin 1998; 16: 382-383.
23. Gosbell IB, Toumasatos V, Yong J, et al. Cure of orthopaedic infection with Scedosporium prolificans, using voriconazole plus terbinafine, without the need for radical surgery. Mycoses 2003; 46: 233-236.
24. Greig JR, Khan MA, Hopkinson NS, et al. Pulmonary infection with Scedosporium prolificans in an immunocompetent individual. J Infect 2001; 43: 15-17.
25. Guerrero A, Torres P, Duran MT, et al. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet 2001; 357: 1267-1268.
26. Hopwood V, Evans EG, Matthews J, Denning DW. Scedosporium prolificans a multi-resistant fungus, from a U.K. AIDS patient. J Infect 1995; 30: 153-155.
27. Howden BP, Slavin MA, Schwarer AP, Mijch AM. Successful control of disseminated Scedosporium prolificans infection with a combination of voriconazole and terbinafine. Eur J Clin Microbiol Infect Dis 2003; 22: 111-113.
28. Husain S, Alexander BD, Munoz P, et al. Opportunistic mycelial fungal infections in organ transplant recipients: Emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003; 37 221-229.
29. Idigoras P, Lopez LC, Garcia-Arenzana JM, Diaz de Tuesta JL, Marin GJ. i Scedosporium inflatum disseminated infection. Enferm Infecc Microbiol Clin 1993; 11: 285.
30. Idigoras P, Garcia-Arenzana JM, Saenz JR, Pineiro L, Marin J. Isolation of Scedosporium prolificans from the air in the room of a patient with leukemia and disseminated infection with this fungus]. Enferm Infecc Microbiol Clin 2000; 18: 426-427.
31. Idigoras P, Perez-Trallero E, Pineiro L, et al. Disseminated infection and colonization by Scedosporium prolificans: A review of 18 cases, - 1999. Clin Infect Dis; 32 1990; 2001: E158-E165.
32. Kumar B, Crawford GJ, Morlet GC. Scedosporium prolificans corneoscleritis: A successful outcome. Aust N Z J Ophthalmol 1997; 25: 169-171.
33. Lopez L, Gaztelurrutia L, Cuenca-Estrella M, et al. [Infection and colonization by Scedosporium prolificans]. Enferm Infecc Microbiol Clin 2001; 19: 308-313.
34. Maertens J, Lagrou K, Deweerdt H, et al. Disseminated infection by Scedosporium prolificans: An emerging fatality among haematology patients. Case report and review. Ann Hematol 2000; 79: 340-344.
35. Malekzadeh M, Overturf GD, Auerbach SB, Wong L, Hirsch M. Chronic, recurrent osteomyelitis caused by Scedosporium-inflatum. Ped Infect Dis J 1990; 9: 357-359.
36. Marco dL, Sadaba P, Lastra Garcia-Baron P, et al. Cerebral scedosporiosis: An emerging fungal infection in severe neutropenic patients: CT features and CT pathologic correlation Eur Radiol 2006; 16: 496-502.
37. Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Severe corneoscleral infection. A complication of beta irradiation scleral necrosis following pterygium excision. Arch Ophthalmol 1993; 111: 947-951.
38. Moriarty AP, Crawford GJ, McAllister IL, Constable IJ. Fungal corneoscleritis complicating beta-irradiation-induced scleral necrosis following pterygium excision. Eye 1993; 7: 525-528.
39. Nenoff P, Gutz U, Tintelnot K, et al. Disseminated mycosis due to Scedosporium prolificans in an AIDS patient with Burkitt lymphoma. Mycoses 1996; 39: 461-465.
40. Nielsen K, Lang H, Shum AC, Woodruff K, Cherry JD. Disseminated Scedosporium prolificans infection in an immuno-compromised adolescent. Pediatr Infect Dis J 1993; 12: 882-884.
41. Oliveira JS, Kerbauy FR, Colombo AL, et al. Fungal infections in marrow transplant recipients under antifungal prophylaxis with fluconazole. Braz J Med Biol Res 2002; 35: 789-798.
42. Pickles RW, Pacey DE, Muir DB, Merrell WH. Experience with infection by Scedosporium prolificans including apparent cure with fluconazole therapy. J Infect 1996; 33: 193-197.
43. Rabodonirina M, Paulus S, Thevenet F, et al. Disseminated Scedosporium prolificans (S. inflatum) infection after single-lung transplantation. Clin Infect Dis 1994; 19: 138-142.
44. Raunikar RA, Foshee WS. Scedosporium inflatum osteomyelitis-successful treatment with long-term amphotericin-B. Clin Res 1989; 37: A60.
45. Salesa R, Burgos A, Ondiviela R, et al. Fatal disseminated infection by Scedosporium inflatum after bone marrow transplantation. Scand J Infect Dis 1993; 25: 389-393.
46. Sanchez AG, Martin CP, Jaurena J, et al. [About the article 'Colonization/infection of a lung transplant by Scedosporium inflatum']. Enferm Infecc Microbiol Clin 1998; 16: 251.
47. Simarro E, Marin F, Morales A, et al. Fungemia due to Scedosporium prolificans: A description of two cases with fatal outcome. Clin Microbiol Infect 2001; 7: 645-647.
48. Singh RP, McCluskey P. Scedosporium prolificans sclerokeratitis 10 years after pterygium excision with adjunctive mitomycin C. Clin Exp Ophthalmol 2005; 33: 433-434.
49. Sparrow SA, Hallam LA, Wild BE, Baker DL. Scedosporium inflatum: first case report of disseminated infection and review of the literature. Pediatr Hematol Oncol 1992; 9: 293-295.
50. Spielberger RT, Tegtmeier BR, O'Donnell MR, Ito JI. Fatal Scedosporium prolificans (S. inflatum) fungemia following allogeneic bone marrow transplantation: Report of a case in the United States. Clin Infect Dis 1995; 21: 1067.
51. Steinbach WJ, Schell WA, Miller JL, Perfect JR. Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide. J Clin Microbiol 2003; 41: 3981-3985.
52. Studahl M, Backteman T, Stalhammar F, Chryssanthou E, Petrini B. Bone and joint infection after traumatic implantation of Scedosporium prolificans treated with voriconazole and surgery. Acta Paediatr 2003; 92: 980-982.
53. Sullivan LJ, Snibson G, Joseph C, Taylor HR. Scedosporium prolificans sclerokeratitis. Aust N Z J Ophthalmol 1994; 22: 207-209.
54. Tapia M, Richard C, Baro J, et al. Scedosporium inflatum infection in immunocompromised haematological patients. Br J Haematol 1994; 87: 212-214.
55. Taylor A, Wiffen SJ, Kennedy CJ. Post-traumatic Scedosporium inflatum endophthalmitis. Clin Experiment Ophthalmol 2002; 30: 47-48.
56. Toy EC, Rinaldi MG, Savitch CB, Leibovitch ER. Endocarditis and hip arthritis associated with Scedosporium inflatum. South Med J 1990; 83: 957-960.
57. Westerman DA, Speed BR, Prince HM. Fatal disseminated infection by Scedosporium prolificans during induction therapy for acute leukemia: a case report and literature review. Pathology 1999; 31: 393-394.
58. Wilson CM, O'Rourke EJ, McGinnis MR, Salkin IF. Scedosporium inflatum clinical spectrum of a newly recognized pathogen. J Infect Dis 1990; 161: 102-107.
59. Wise KA, Speed BR, Ellis DH, Andrew JH. Two fatal infections in immunocompromised patients caused by Scedosporium inflatum. Pathology 1993; 25: 187-189.
60. Wood GM, McCormack JG, Muir DB, et al. Clinical features of human infection with Scedosporium inflatum. Clin Infect Dis 1992; 14: 1027-1033.
61. Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole: Clinical experience with 107 patients. Antimicrob Agents Chemother 2008; 52: 1743-1750.
62. Cuenca-Estrella M, Ruiz-Diez B, Martinez-Suarez JV, Monzon A, Rodriguez-Tudela JL. Comparative in vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 1999; 43: 149-151.
63. Cuenca-Estrella M. Combinations of antifungal agents in therapy - what value are they? J Antimicrob Chemother 2004; 54: 854-869.
64. DelPoeta M, Schell WA, Perfect JR. In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds Antimicrob Agents Chemother 1997; 41: 1835-1836.
65. Johnson EM, Szekely A, Warnock DW. In vitro activity of voriconazole, itraconazole and amphotericin B against filamentous fungi. J Antimicrob Chemother 1998; 42: 741-745.
66. Carrillo AJ, Guarro J. In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother 2001; 45: 2151-2153.
67. Meletiadis J, Meis JF, Mouton JW, et al. In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates. Antimicrob Agents Chemother 2002; 46: 62-68.
68. Meletiadis J, Mouton JW, Rodriguez-Tudela JL, Meis JF, Verweij PE. In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans. Antimicrob Agents Chemother 2000; 44: 470-472.
69. Meletiadis J, Mouton JW, Meis JF, Verweij PE. In vitro drug interaction modeling of combinations of azoles with terbinafine against clinical Scedosporium prolificans isolates. Antimicrob Agents Chemother 2003; 47: 106-117.
70. Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. In vitro activities of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans Antimicrob Agents Chemother 2008; 52: 1136-1139.
71. Gil-Lamaignere C, Roilides E, Maloukou A, et al. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum. J Antimicrob Chemother 2002; 50 1027-1030.
72. Gil-Lamaignere C, Roilides E, Mosquera J, Maloukou A, Walsh TJ. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum. Antimicrob Agents Chemother 2002; 46: 2234-2237.
73. Ortoneda M, Capilla J, Pujol I, et al. Liposomal amphotericin B and granulocyte colony-stimulating factor therapy in a murine model of invasive infection by Scedosporium prolificans. J Antimicrob Chemother 2002; 49: 525-529.
74. Ortoneda M, Capilla J, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004; 50: 247-251.
75. Capilla J, Yustes C, Mayayo E, et al. Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits. Antimicrob Agents Chemother 2003; 47: 1948-1951.
76. Simitsopoulou M, Gil-Lamaignere C, Avramidis N, et al. Antifungal activities of posaconazole and granulocyte-macrophage colon-stimulating factor ex vivo and in mice with disseminated infection due to Scedosporium prolificans. Antimicrob Agents Chemother 2004; 48: 3801-3805.